AI-generated summary
This study protocol describes a planned 12-month randomized trial in children aged 8 to 12 with myopia, comparing repeated low-level red light therapy combined with defocus-incorporated multiple segment spectacle lenses against the lenses alone. The authors report that the trial was designed to assess efficacy and safety, with axial length change at 12 months as the primary outcome. No results are reported, as this is a protocol only.
- Participants
- 66
- Who or what was studied
- Chinese school-aged children aged 8-12 years with myopia (spherical equivalence between -0.50 D and -6.00 D under cycloplegia in both eyes)
- Limits stated in the abstract
- This is a study protocol with no results reported, and the trial is single-center.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on trialsjournal.biomedcentral.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Myopia, Repeated low-level red light, Trial registration, Red light therapy, Primary outcome, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.